Chemed (CHE) Stock: Buy, Sell, or Hold?
CHE - Chemed Corporation
$515.97
1.57 (0.31%)
▲
5d:
-1.62%
30d:
-4.63%
90d:
+22.6%
HOLD
MODERATE Confidence
Analysis Updated: Sep 11, 2026 12:00 AM ET
Earnings: Oct 27, 2026
Get Alerted When CHE Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: CHE is fairly valued with market pricing in 3.3% annual growth. Fine to hold or accumulate slowly on dips.
📊 HOLD: CHE is fairly valued with market pricing in 3.3% annual growth. Fine to hold or accumulate slowly on dips.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$622.99
Based on 5.9% avg growth
INTRINSIC VALUE TODAY
$386.83
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 17.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: CHE is currently trading at $515.97, which is considered oversold relative to its 30-day fair value range of $519.81 to $543.84. From a valuation perspective, the stock is trading at a premium (Forward PE: 18.8) compared to its historical average (17.0). At these levels, the market is pricing in 3.3% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, CHE is in a strong uptrend. The price is currently testing key support at $509.01. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock scores a mixed 41/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, CHE is in a strong uptrend. The price is currently testing key support at $509.01. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock scores a mixed 41/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$519.81 -
$543.84
Company Quality Score
55/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
75.7%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (41/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($552.00)
- NEUTRAL: Market pricing in 3.3% annual earnings growth - fairly valued
- NEUTRAL: Bottoming setup forming (41/100) — watch for confirmation
Trading Range Analysis
30-Day Trading Range
$519.81 -
$543.84
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$509.01
Resistance Level
$534.17
Current Trend
Strong Uptrend
Technical data as of
Sep 11, 2026
Fundamental Context
Forward P/E (Next Year Est.)
18.75
Wall Street Target
$552.00
(+7.0%)
Revenue Growth (YoY)
8.8%
Earnings Growth (YoY)
43.7%
Profit Margin
10.6%
Valuation Premium vs History
+3.3% premium
PE vs Historical
18.8 vs 17.0
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+3.3%
(market-implied from PE analysis)
1-Year Target
$533.00
(+3%)
2-Year Target
$550.59
(+7%)
3-Year Target
$568.76
(+10%)
3-Yr Target (if PE normalizes)
(PE: 19→17)
PE COMPRESSION
$515.80
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.2, Growth: 7.8%)
$696.38
(+35%)
Base:
(SPY PE: 18.7, Growth: 7.8%)
$647.20
(+25%)
Bear:
(PE: 15.9, Growth: 7.8%)
$550.12
(+7%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (26x PE), but valuation improves significantly next year (19x PE) as earnings recover.
Trailing PE: 26.11 | Current EPS (TTM): $19.70
Bull Case
$790.60
(+53%)
Analyst growth 39.7%, PE expands to 28.7
Base Case
$718.72
(+39%)
Market implied 39.7%, PE stable at 26.1
Bear Case
$349.79
(-32%)
Severe decline -20.0%, PE contracts to 22.2
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: September 13, 2026 2:58 AM ET
Data refreshes hourly during market hours. Next update: 3:58 AM
Data refreshes hourly during market hours. Next update: 3:58 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CHE showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Care Facilities Stocks
Top-rated stocks in Medical Care Facilities by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
THC
Tenet Healthcare Corpora… |
STRONG BUY
22 analysts |
$285 | 61 BUY |
|
HCA
HCA Healthcare, Inc. |
BUY
25 analysts |
$451 | 50 HOLD |
|
EHC
Encompass Health Corp |
STRONG BUY
12 analysts |
$148 | 55 HOLD |
|
CMPS
Compass Pathways Plc |
STRONG BUY
11 analysts |
$24 | 52 HOLD |
|
ADUS
Addus HomeCare Corporati… |
STRONG BUY
11 analysts |
$135 | 56 HOLD |